Sponsor:
Massachusetts General Hospital
Code:
NCT04902833
Conditions
Pyruvate Kinase Deficiency
Pyruvate Kinase Deficiency Anemia
Hereditary Hemolytic Anemia
Myelodysplastic Syndromes
Myelodysplastic/Myeloproliferative Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Blood Draw
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-23. This information was provided to ClinicalTrials.gov by Massachusetts General Hospital on 2025-08-29.